结节病患者在使用皮质类固醇治疗期间肺功能的改善率。
Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.
作者信息
Goldstein D S, Williams M H
出版信息
Thorax. 1986 Jun;41(6):473-4. doi: 10.1136/thx.41.6.473.
Abstract
Serial measurements of vital capacity were obtained in 11 patients with impaired pulmonary function due to sarcoidosis during 12 courses of corticosteroid treatment. Vital capacity improved promptly and approached a maximum value in about three weeks. A three week trial is probably sufficient to show whether or not corticosteroids are effective in a patient with sarcoidosis.
摘要
在11例因结节病导致肺功能受损的患者接受12个疗程的皮质类固醇治疗期间，对肺活量进行了连续测量。肺活量迅速改善，并在大约三周内接近最大值。为期三周的试验可能足以表明皮质类固醇对结节病患者是否有效。
相似文献
1
Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.结节病患者在使用皮质类固醇治疗期间肺功能的改善率。
Thorax. 1986 Jun;41(6):473-4. doi: 10.1136/thx.41.6.473.
2
Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis.在肺结节病长期皮质类固醇治疗方面的丰富经验。
Ann N Y Acad Sci. 1976;278:722-31. doi: 10.1111/j.1749-6632.1976.tb47087.x.
3
The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study.
Ann N Y Acad Sci. 1986;465:695-701. doi: 10.1111/j.1749-6632.1986.tb18548.x.
4
[Effect of prednisolone on the diffusion capacity of the lungs in sarcoidosis].[泼尼松龙对结节病患者肺弥散功能的影响]
Klin Med (Mosk). 1974 Mar;52(3):115-20.
5
Lung and airway mechanics in early pulmonary sarcoidosis.
Bull Eur Physiopathol Respir. 1979 May-Jun;14(3):299-310.
6
Sarcoidosis: course and treatment.
Med Clin North Am. 1977 Nov;61(6):1267-78. doi: 10.1016/s0025-7125(16)31261-5.
7
A ten-year study of corticosteroid treatment of pulmonary sarcoidosis.
Johns Hopkins Med J. 1974 May;134(5):271-83.
8
Do chest radiographic findings reflect the clinical course of patients with sarcoidosis during corticosteroid withdrawal?胸部X线检查结果能否反映结节病患者在停用皮质类固醇期间的临床病程？
AJR Am J Roentgenol. 1990 Mar;154(3):481-5. doi: 10.2214/ajr.154.3.2106208.
9
Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis.皮质类固醇治疗对结节病患者肺血流动力学的影响。
Eur Respir J. 1990 Apr;3(4):403-7.
10
[Pulmonary sarcoidosis and lung function (author's transl)].
Prax Pneumol. 1974 Feb;28(2):99-108.
引用本文的文献
1
A Prospective Review of the Results of Patients Treated and Followed up for a Diagnosis of Sarcoidosis.对经治疗及随访的结节病诊断患者结果的前瞻性综述。
Turk Thorac J. 2018 Jan;19(1):1-6. doi: 10.5152/TurkThoracJ.2017.17028. Epub 2017 Sep 27.
2
The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.成人弥漫性实质性肺疾病的诊断、评估与治疗。引言。
Thorax. 1999 Apr;54 Suppl 1(Suppl 1):S1-14. doi: 10.1136/thx.54.suppl_1.s1.
本文引用的文献
1
Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies.通过肺功能研究确定的接受和未接受皮质类固醇治疗的肺结节病病程。
Am J Med. 1966 Oct;41(4):541-51. doi: 10.1016/0002-9343(66)90216-6.
2
Long-term study of pulmonary sarcoidosis. The effect of steroid therapy as evaluated by pulmonary function studies.肺结节病的长期研究。通过肺功能研究评估类固醇疗法的效果。
J Chronic Dis. 1969 Jul;22(2):69-86. doi: 10.1016/0021-9681(69)90060-5.
3
A ten-year study of corticosteroid treatment of pulmonary sarcoidosis.
Johns Hopkins Med J. 1974 May;134(5):271-83.
4
Pulmonary function follow-up to 120 patients with sarcoidosis.对120例结节病患者进行肺功能随访。
Ann N Y Acad Sci. 1976;278:301-7. doi: 10.1111/j.1749-6632.1976.tb47041.x.
5
Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease.肺结节病的皮质类固醇治疗。II期疾病隔日和每日剂量的前瞻性评估。
Scand J Respir Dis. 1979 Aug;60(4):215-21.
Zotero 插件